News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Alliances (World)
Oncodesign SA Has Entered Into A Services Agreement With Eisai Inc. (ESALF.PK) To Develop A New Personalized Medicine Program In Earlier Line Metastatic Breast Cancer Treatment 12/17/2014
Orexo AB (ORXOF) Receives Million 5£ Milestone Payment For Abstral® In Europe And Zubsolv® Continues Strong Market Share Growth In The US 12/17/2014
Generex Biotechnology Corporation (GNBT) Announces Participation In MedCannAccessCannScience Partnership On Non-Smoked Forms Of Marijuana 12/17/2014
Addex Therapeutics (ADXN.SW) Amends mGlu2PAM Collaboration Agreement And Receives USD757,000 12/17/2014
Lightlake Therapeutics Inc. (LLTP), Adapt Pharma Forge Deal Worth $55 Million 12/16/2014
Johnson & Johnson (JNJ) Pulls Out Of Program To Develop Bowel Disease Drug 12/16/2014
Carlina Technologies Signs A Partnership Agreement With Atlangram To Develop Controlled-Release Forms Of Antibiotics Targeting Osteoarticular Diseases 12/16/2014
Aseptix Signs Global Technology License With Ecolab Inc. (ECL) 12/16/2014
CMC Biologics And OncoSynergy Enter Into An Agreement For Accelerated Process Development And GMP Manufacture Of An Investigational Drug To Combat Ebola 12/16/2014
Foamix Pharmaceuticals, Ltd. (FOMX) Earns $2.5 Million Milestone Payment From Bayer HealthCare (BAY) 12/16/2014
Regeneron (REGN), Sanofi (SAN.PA) Test The Public's Cholesterol IQ To Prep For Alirocumab Launch 12/16/2014
GE Healthcare Life Sciences Joins SBC's Neurodegenerative Disease Challenge 12/15/2014
Anthera Pharmaceuticals, Inc. (ANTH) Licenses Japan Rights For Blisibimod To Zenyaku Kogyo 12/15/2014
Luqa Pharmaceuticals In-licenses Novel Wound Product From Histocell 12/10/2014
Pfizer (PFE) Grabs Rights To Preclinical Drugs From Startup In $29 Million+ Deal 12/9/2014
Easton Pharmaceuticals (OP: EAPH) Announces Positive Updates, Changes To Its OTC Therapeutic Products, Manufacturing And North American Distributorship 12/8/2014
SYGNIS AG Signs Initial Non-Exclusive Distribution Agreement For Its First Proprietary Product With BioCat GmbH 12/8/2014
Leading Bone Repair Company BoneSupport And Regenerative Medicine Company Orthocell Announce A Heads Of Agreement 12/8/2014
Evotec AG (EVTG.F) Seals $310M Research Deal; Acquires Sanofi (SAN.PA)'s Toulouse Operations 12/4/2014
GE Healthcare Life Sciences Release: Licenses CRISPR Gene Engineering Technology Patents From Broad Institute 12/4/2014
Nexvet Announces Collaboration And Distribution Agreement With Virbac 12/3/2014
Garmatex Technologies, Inc. Release: New Partnership Aims To Produce Innovative Healthcare Products To Prevent The Spread Of Deadly Illnesses In Hospitals 12/3/2014
GeNeuro, Servier Ink $455M MS Drug Pact 12/2/2014
Astellas Pharma Inc. (ALPMY), Janssen Biotech Inc. (JNJ) To End Collaboration On RA Drug ASP015K 12/2/2014
Nuvilex (NVLX) Obtains Exclusive Worldwide License To Develop Disease Treatments That Combine Cell-In-A-Box(R) And Cannabinoid-Based Medicine 12/2/2014
BioVersys AG And Enamine Ltd. Announce Extension Of Drug Discovery Collaboration To Address Multidrug-Resistant Bacterial Infections 12/2/2014
Dynavax Technologies Corporation (DVAX) Regains Full Rights To Investigational TLR 7/9 Inhibitor DV1179 Following Expiration Of Collaboration With GlaxoSmithKline (GSK) 12/1/2014
Sanofi (SAN.PA), Pozen, Inc. (POZN) Terminate U.S. License Agreement For Gastric Ulcer Drugs 12/1/2014
Mylan Inc. (MYL), Gilead Sciences, Inc. (GILD) Ink Agreement Covering Non-Exclusive TAF Rights 12/1/2014
nanoPET Pharma Initiates R&D Partnership With Boehringer Ingelheim Corporation 12/1/2014
flutiform® Launched In Spain; Abriff® Launched In Italy SkyePharma Inc. (SKYE) To Receive €2 Million Milestone From Mundipharma International Limited 12/1/2014
IP Group plcModern Biosciences plc Announces Collaboration Worth Up To £176m With Johnson & Johnson (JNJ) Innovation And Janssen Biotech Inc. (JNJ) 12/1/2014
Flamel Technologies (FLML) Sells Development And Manufacturing Facility In Pessac, France To Recipharm AB 12/1/2014
Nordic Nanovector And Affibody Collaborate On Advanced Radio-Immunotherapies Program For Multiple Myeloma 12/1/2014
HanAll BioPharma Co., Ltd. (009420.KS) And Open Monoclonal Technology Announce Collaboration 12/1/2014
AEterna Zentaris (AEZS) And Sinopharm A-Think Sign Master Collaboration Agreement For Zoptarelin Doxorubicin In China 12/1/2014
Nordic Nanovector And Affibody Collaborate On New Advanced Radio-Immunotherapies Program For Multiple Myeloma 11/26/2014
$1 Billion Oncology Alliance Between Menarini Group & Oxford BioTherapeutics Initiates First-In-Human Study Of Enhanced Antibody For Treatment Of Acute Myeloid Leukemia 11/25/2014
Trimel Pharmaceuticals (TRL.TO), Endo International (ENDP) Ink NATESTO Deal For Up To $195M 11/24/2014
GlaxoSmithKline (GSK) Shareholders To Vote On Novartis AG (NVS) Deal On Dec. 18 11/24/2014
MRC Technology And Yabao Pharmaceuticals Announce Exclusive Partnership In China To Develop Novel Therapeutics For Parkinson’s Disease 11/24/2014
Camurus, Braeburn Pharmaceutical Ink Licensing Deal Worth Up To $151 Million 11/21/2014
Yabao Pharmaceuticals And MRC Technology Announces Exclusive China Partnership 11/21/2014
Ipsen (IPN.PA) And CNRS Create The "Archi-Pex" Joint Research And Innovation Lab, In Collaboration With The University Of Rennes 1 And CEA 11/20/2014
Sunshine Biopharma, Inc. Signs Agreement With Lonza Biologics Inc. (LONN.VX) To Manufacture Its Lead Anti-Cancer Compound, Adva-27a 11/20/2014
Ikaria Inc. And Lee's Pharmaceutical Announce Strategic Partnership For The Registration And Commercialization Of Ikaria's INOMAX Total Care Package In The People's Republic Of China, Hong Kong, Macau And Taiwan 11/19/2014
Pfizer (PFE), Merck KGaA (MKGAF.PK) Strike A $2.9B Deal To Develop Cancer Tumor Treatment 11/18/2014
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For Tanibirumab, An Anti-VEGFR2/KDR Mab With Pharmabcine 11/18/2014
A*STAR’s Genome Institute of Singapore Strengthens Its Genome Sequencing Capabilities Through Collaboration With BT 11/18/2014
MYMETICS Corporation Announces New Collaboration To Advance The Development Of An Innovative Malaria Vaccine Candidate 11/18/2014
Generex Biotechnology Corporation (GNBT) Announces Collaboration On Medicinal Cannabis 11/18/2014
Omnicell And King Faisal Specialist Hospital And Research Centre Collaborate To Deliver Excellence In Automation 11/18/2014
MiNA Completes Exclusive License Agreement With University of California, San Francisco (UCSF) 11/18/2014
Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) Denies Calling Off JV With Merck & Co. (MRK) 11/17/2014
Cellmid Signs Evaluation and Option to License Agreement With Zoetis (ZTS) 11/17/2014
Merz Pharma Canada Ltd. Announces Exclusive Distribution Arrangement With Ulthera 11/17/2014
Bone Therapeutics & Kasios Collaborate On Novel Product For Optimisation Of Spinal Fusion Procedures 11/17/2014
Cardiome Pharma Corp. (COM.TO) Enters Commercialization Agreement With Aspen For BRINAVESS® In South Africa 11/17/2014
Baring Asia Says Agrees To Buy Japan Drugmaker Bushu From Tokio Marine 11/17/2014
Servier Bets $1 Billion+ On Intarcia Therapeutics, Inc.'s Diabetes Device 11/13/2014
Boehringer Ingelheim Corporation Passes on Anthera, Inc.'s CV Antibody Option 11/13/2014
Onxeo Confirms Receipt Of The $25M Milestone Payment On Beleodaq® 11/13/2014
Harrington Discovery Institute At University Hospitals, Cleveland, Forms Affiliation With University of Oxford To Create An International Initiative To Drive Early-Stage Drug Discovery And Development 11/13/2014
Unilife Corporation (UNIS) and Flextronics (FLEX) Enter Into Global Strategic Alliance 11/13/2014
Novartis AG (NVS) To Deliver Three Million Malaria Treatments For Kids In Zambia 11/13/2014
ABIVAX Signs Agreement With The Finlay Institute To Commercialise Meningococcal And Typhoid Vaccines In Asia And Latin America 11/12/2014
Support For SBC's OI Challenge From Drug Discovery Specialist Astex Pharmaceuticals (ASTX) 11/11/2014
Ascletis, Inc. Gains Exclusive China Market Rights From Presidio Pharmaceuticals, Inc. To Clinical Stage Hepatitis C Virus (HCV) NS5A Inhibitor PPI-668 11/10/2014
Cartagenia Partners With CollabRx, Inc. To Provide Pathology Laboratories And Cancer Centers Access To Personalized Information On Therapeutic Options 11/10/2014
ScinoPharm And Nanjing King-Friend Biochemical Pharmaceutical Team Up To Jointly Enter The Chinese Market For New Drugs 11/10/2014
Cambio Ltd To Sell BioPointe Scientific’s World-Class Lab Consumables 11/7/2014
Vectura Group plc (VEC.L) VR315 U.S. Development Milestone 11/7/2014
National Heart Research Institute Singapore And Thermo Fisher Scientific (TMO) Teams Up To Further Enhance Stem Cell Research Techniques 11/6/2014
Otonomy, Inc. (OTIC) Obtains Rights To Gacyclidine Data From Ipsen (IPN.PA) To Support Development Of OTO-311 As A Treatment For Tinnitus 11/6/2014
Hitachi, Ltd. (HIT) And Qatar University Enter Into A Comprehensive Industry-University Collaboration Agreement Concerning Environmental And Energy Efficiency Technologies In The Infrastructure Systems Field 11/6/2014
Astellas Pharma Inc. (ALPMY), Proteostasis Therapeutics, Inc. Forge $1.2 Billion Genetic Disease Drug Pact 11/5/2014
Charles River Laboratories (Massachusetts)'s Early Drug Discovery Business And CHDI Foundation Extend Huntington’s Disease Collaboration 11/5/2014
Advinus Therapeutics (P) Ltd., A TATA Enterprise, Meets Milestone In Drug Discovery Alliance 11/5/2014
AstraZeneca PLC (AZN) And Pharmacyclics, Inc. (PCYC) Enter Clinical Trial Collaboration To Evaluate IMBRUVICA® In Hematologic Cancers 11/5/2014
Genmab A/S (GEN.CO) Moves Cancer Drug Pact To Novartis AG (NVS) From GlaxoSmithKline (GSK) 11/4/2014
AstraZeneca PLC (AZN) Strengthens Cancer Biz With Johnson & Johnson (JNJ), Pharmacyclics, Inc. (PCYC) Deals 11/4/2014
Carlina Technologies Signs A Partnership Agreement With Genbiotech To Develop A Sustained-Release Protein Formulation For Cartilage Repair 11/4/2014
Pharming Group (PHGUF.PK) Confirms Receipt Of US$20 Million Milestone Payment From Salix Pharmaceuticals, Ltd. (SLXP) 11/4/2014
ex scientia Ltd. Partners With Sunovion Pharmaceuticals Inc. To Research New Medicines For Psychiatric Disorders 11/4/2014
Moberg Pharma AB (Formerly known as Moberg Derma) Increases Efficiency And Reduces Costs Through Expanded Partnership With Emerson Group 11/4/2014
Imprimis Pharmaceuticals (immy) Signs Distribution Agreement To Bring Go Dropless™ Proprietary Formulations To Ophthalmologists In Puerto Rico 11/4/2014
Bone Marrow Transplant Technology Commercialisation Advances With Cytomatrix Deal 11/3/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Walks Away From Intra-Cellular Therapies, Inc. CNS Disorders Deal 11/3/2014
Global Bioenergies Proceeds With Another 100,000 Euro Draw Down On Its Standby Equity Distribution Agreement 11/3/2014
Sangui BioTech International Inc. (SGBI): Laboratorios Silanes Start Marketing Granulox In Mexico 11/3/2014
Clinical Network Services (CNS) Signs Cooperative Agreement With BD Consultancy 11/3/2014
Lonza Group Ltd. (LZAGY.PK) And Celladon Corporation Establish A Strategic Commercial Manufacturing Collaboration For MYDICAR® 11/3/2014
Bristol-Myers Squibb Company (BMY) And Lonza Group Ltd. (LZAGY.PK) Expand Manufacturing Agreement 10/30/2014
Medivir AB (MVRBF) And County Councils Conclude Agreement On Olysio®-Based Treatment For Hepatitis C 10/30/2014
Chugai Pharmaceutical Co., Ltd. (Japan) Licenses ISPRI/Optimatrix Platform From EpiVax, Inc. For De-Risking Biologics 10/30/2014
MediGene AG (MDGEF.PK)'s Licensee Enters Promotion Agreement To Expand Veregen® Product Sales In The United States 10/30/2014
Eli Lilly (LLY), Boehringer Mannheim Corporation Revise Terms Of Diabetes Drugs Alliance 10/29/2014
Clean TeQ Holdings Limited (ASX:CLQ) Teams Up With Queensland University of Technology's Institute For Future Environments 10/29/2014
Amgen (AMGN), Ono Pharmaceutical Company, Ltd., Sanofi (SAN.PA) Team Up With Academia On Proteins Project 10/28/2014
Bristol-Myers Squibb Company (BMY) Forges $475 Million Pact For Rights To f-Star's Cancer Drug 10/28/2014
Janssen Signs Translational Medicine MOU With Shanghai Ruijin Hospital 10/28/2014
PharmAbcine Announces Global Licensing Deal With Triphase Accelerator For VEGFR-2/TIE 2 Bi-Specific Antibody 10/28/2014
Enerkem Announces New Project Partnership In China 10/28/2014
Vernalis PLC (VNLPY.PK) Announces CTI BioPharma Becomes Worldwide Licensee For Tosedostat 10/27/2014
PlasmaTech Biopharmaceuticals Signs Expanded MuGard Licensing Agreement With Norgine For Australia And New Zealand Territories 10/27/2014
Calchan And Galapagos NV (GLPG.BR) Collaborate On Osteoarthritis Pain Research 10/27/2014
Five Prime Therapeutics, Inc. (FPRX) Snags An Expanded Deal Worth $196.3 Million With GlaxoSmithKline (GSK) 10/24/2014
Genmab A/S (GEN.CO) Banks $10 Million Milestone Payment From Janssen Biotech Inc. (JNJ) 10/24/2014
Covidien (COV) Joins Forces With American Lung Association To Help Women Understand Their Increased Risk Of Lung Cancer 10/23/2014
R-Tech Ueno: Sucampo Pharmaceuticals, Inc. (SCMP) And Takeda (TKPYY) Enter Into Global Licensing Agreement For AMITIZA® (Lubiprostone) 10/23/2014
Lucideon (Formerly Known As CERAM) To Jointly Run Biodensol Project 10/23/2014
Inocucor Technologies And McGill University To Collaborate On Bio-Stimulants For Large-Scale Agriculture 10/23/2014
Neovacs SA And Kepler Cheuvreux Sign A Financing Project 10/23/2014
MorphoSys AG To Receive Milestone Payment For Guselkumab Phase 3 Program 10/23/2014
Sucampo Pharmaceuticals, Inc. (SCMP), Takeda (TKPYY) Forge $55 Million Deal For Amitiza® 10/22/2014
Lexicon Pharmaceuticals, Inc. (LXRX), Ipsen (IPN.PA) Strike Licensing Deal Worth $145 Million 10/22/2014
GlaxoSmithKline (GSK), Johnson & Johnson (JNJ) Join Forces To Make Millions Of Ebola Vaccine Doses 10/22/2014
Xbrane Bioscience Signs Major Biosimilar Agreement With Global Indian Pharmaceutical Company 10/22/2014
Quest PharmaTech Inc. To Market And Distribute Premium Anti-Wrinkle Skin Care Product, Bellus Skin™; Dr. Jacqueline Shan, Creator Of COLD FX®, To Assist 10/22/2014
Masters Speciality Pharma Signs Exclusivity Agreement With Speciality European Pharma For The Exclusive Distribution Of Mitocin®/Mitem® 20mg (mitomycin) 10/22/2014
Genentech (RHHBY), NewLink Genetics Strike $1 Billion+ Cancer Deal 10/21/2014
Addex Therapeutics (ADXN.SW) And The Charcot-Marie-Tooth Association Enter Collaboration To Advance ADX71441 In Charcot-Marie-Tooth 1A Disorder 10/21/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Amendment To Common Share Purchase Agreement With Lincoln Park Capital Fund, LLC 10/21/2014
Sysfera And Kitware Partner To Integrate HPC Technologies For Improved Scientific Data Analysis 10/21/2014
Forendo Pharma Licenses U.S. Fispemifene Rights To Apricus Biosciences (APRI) In Deal Worth $305 Million 10/20/2014
Hemispherx Biopharma (HEB) Announces Strategic Relationship With Squire Patton Boggs, Washington, DC As Governmental Counsel In Fight Against Ebola 10/20/2014
Sirona Biochem Announces Research Collaboration With Aegilops Applications 10/20/2014
Calixar And Aston University Together In Collaborative Research To Tackle Multidrug Resistance Targets 10/20/2014
Clean TeQ Holdings Limited (ASX:CLQ) And SIDRI Sign Heads Of Agreement 10/20/2014
Astellas Pharma Inc. (ALPMY), CoMentis, Inc. Terminate Alzheimer's Agreement 10/17/2014
Sihuan Pharmaceutical Announces Second Anti-Virus Partnership With AMMS 10/17/2014
Cardiorentis AG And Roche (RHHBY) Announce Collaboration To Establish Therapeutic Impact Of Ularitide 10/16/2014
Moderna Therapeutics, Inc. To Collaborate With Karolinska Institute And Karolinska University Hospital On Discovery Of New Messenger RNA Therapeutics™ 10/16/2014
AstraZeneca PLC (AZN) Strengthens Partnership With The University of Cambridge 10/16/2014
Deinove Teams Up With MBI, Pioneer Of Afex Technology, To Evaluate Its Process On Industrial Biomass 10/15/2014
Auspherix And Domainex Announce Collaboration To Develop New Drugs To Treat Antibiotic-Resistant Bacterial Infections 10/15/2014
Embattled Wilex AG (WL6.DE) Sells Unnamed Tumor Drug To Roche (RHHBY) For $65.8M 10/14/2014
New Oncology And Gustave Roussy Announce Collaboration On Genetic Testing 10/14/2014
BioSilta And Sigma-Aldrich Corporation (SIAL) Sign Global Distribution Agreement 10/14/2014
Imaxio Signs An Option For A License Agreement With The German Cancer Research Center (DKFZ) 10/14/2014
Advanced Biological Laboratories SA (ABL), University of Hong Kong, And The Hong Kong Polytechnic University Decide To Join Forces To Develop A Deep-Sequencing Tuberculosis Solution 10/14/2014
MRC Technology And Proximagen Group plc. Collaborate To Develop Novel Therapeutics For Inflammatory And Autoimmune Disease 10/13/2014
Onxeo Reaches Second Milestone Of BPIFrance Grant Dedicated To Livatag® Development As Part Of National Institute for Clinical Excellence (NICE) Consortium 10/13/2014
Pharming Group (PHGUF.PK) And Swedish Orphan Biovitrum Amend And Extend Ruconest Distribution Agreement 10/13/2014
Bristol-Myers Squibb Company (BMY), Pharmacyclics, Inc. (PCYC), And Janssen Research & Development Announce Clinical Collaboration To Evaluate OPDIVO® (Nivolumab) And IMBRUVICA®(Ibrutinib) In Non-Hodgkin Lymphoma 10/13/2014
Nanobiotix Reaches The Second Milestone Payment Of BPIFrance Dedicated To NBTXR3 Development In Liver Cancers 10/13/2014
Hikma Pharmaceuticals Enters Partnership With Eisai Company, Ltd. (ESALY.PK) For Distribution Of First-In-Class Epilepsy Treatment Fycompa® In Middle East 10/13/2014
Week In Review: Lee's Pharmaceutical Pays $50 Million For Novel Cancer Drug From Sorrento Therapeutics, Inc. 10/13/2014
Sihuan Pharma Buys Rights To Ebola Drug From China's AMMS 10/13/2014
Oxford BioMedica PLC (OXB.L) Inks Transformational $90 Million Deal With Novartis AG (NVS) 10/10/2014
We've Secured Third Biosimilar License: Stada CEO 10/10/2014
ContraFect Corporation (CFRXU) And China's IVDC Collaborate On Universal Flu Treatment 10/10/2014
ContraFect Corporation (CFRXU) And National Institute For Viral Disease Control And Prevention, China CDC Sign Agreement To Collaborate On Universal Influenza Treatment 10/9/2014
A*STAR’s Simtech Joins Hands With 8 Companies To Overcome Counting, Tracking And Supply Chain Woes 10/9/2014
Tekmira (TKMR) Working Hand In Hand With WHO On Ebola Drug, Says CEO 10/8/2014
BASF And Colorcon, Inc. Cooperate On Kollicoat® IR For Ready-To-Use Pharmaceutical Coating Solutions 10/8/2014
Ubiquigent And University of Dundee Announce Collaboration To Develop Novel Ubiquitin System Targeted Compound Libraries 10/8/2014
Dilafor Signs Supply And Partnership Agreement With OPOCRIN S.p.A 10/8/2014
Cardio3 BioSciences Awarded Preferred Access Rights To Mayo Clinic Center For Regenerative Medicine Portfolio 10/8/2014
Hyperion Therapeutics (HPTX), Clal Biotechnology Industries Resolve Dispute Over $570 Million Biotech Problem 10/7/2014
Merck Serono, Institute Of Cancer Research, Wellcome Trust To Co-Develop Cancer Drugs 10/7/2014
Ariad Pharmaceuticals, Inc. (ARIA), Bellicum Pharmaceuticals, Inc. Revise Pact; Ariad Will Receive $50 Million In Three Installments 10/6/2014
The Reason Why Takeda Pharmaceutical Co. Ltd. (TKPYY) May Pay MacroGenics, Inc. (MGNX) Up To $1.6 Billion For Four Molecules That Don't Yet Exist 10/6/2014
Novartis AG (NVS) Teams Up With Bristol-Myers Squibb Company (BMY) To Test Lung Cancer Drugs 10/6/2014
Sorrento Therapeutics, Inc., Lee's Pharma Forge $49.6 Million Pact 10/6/2014
India Brand Equity Foundation (IBEF), Release: Government Of India And Pharma Industry Jointly Form The India – Responsible Healthcare Trust 10/6/2014
Lockheed Martin Corporation And Yissum Ltd. Sign Long Term Research Collaboration Agreement 10/6/2014
ARTES Biotechnology, instrAction and Q-Biologicals Join Forces for Veterinary Vaccine Development 10/6/2014
Horizon Discovery Group Signs Co-Exclusive Commercial Agreement With Haplogen Genomics 10/6/2014
Collaboration With Dr. Stephen Waxman Of Yale University To Evaluate Pharmacology Of Nav1.7 Mutations In Chronic Pain Disorders 10/6/2014
D&A Pharma Signs Licensing And Distribution Agreement With Grupo JUSTE For ALCOVER® In Spain And Central America 10/3/2014
A*STAR And Japan Science And Technology Agency Renews Research Cooperation 10/3/2014
NetScientific’s Subsidiary, Glycotest Begins A New Research Collaboration With Oncimmune LLC 10/3/2014
Cambridge Research Biochemicals Signs Licensing Deal With The Scripps Research Institute 10/2/2014
VolitionRX Announces Prostate Cancer Collaboration With The University of Texas MD Anderson Cancer Center 10/2/2014
Oxford BioTherapeutics And Berlin-Chemie/Menarini Group Progress Antibody-Drug Conjugate As Second Clinical Development Candidate In $1 Billion Oncology Investment Alliance 10/2/2014
MacroGenics, Inc. (MGNX), Takeda Pharmaceutical Co. Ltd. (TKPYY) Draw Up $1.6B DART Pact 10/1/2014
Bitplane Brings Voloom To The Wider Life Sciences Market 10/1/2014
MannKind Corporation (MNKD) Pockets $150 Million Upfront Payment From Sanofi (France) (SAN.PA) 9/30/2014
Horus Pharma And NovaMedica Sign Agreement To Market A Portfolio Of Eye Care Products In Russia 9/30/2014
DanDrit Biotech A/S Signs Agreement To Commence Clinical Trials Of MelcancerVac® 9/30/2014
Celerion Expands Ophthalmological Capabilities To Patient Populations In Collaboration With Queen’s University, Belfast. 9/30/2014
Lead Discovery Center Enters First Collaboration With The Helmholtz Association 9/30/2014
Evotec AG (EVTG.F) Receives Milestone As Part Of Its Multi-Target Alliance With Bayer HealthCare (BAY) 9/30/2014
Pfizer (PFE), Kyowa Hakko Kirin Team Up On Immuno-Oncology Combination Study 9/30/2014
Hemispherx Biopharma (HEB) Expands Research On Potential Ebola Treatments To Five Independent Experts/Institutional Collaborators 9/29/2014
Kamada Ltd. (KMDA) Extends Glassia Agreement With Baxter International, Inc. (BAX) 9/29/2014
Atox Bio Awarded Contract Worth Up To $24 Million For The Development Of AB103 By The Biomedical Advanced Research and Development Authority (BARDA) 9/29/2014
MetaSysX, Potsdam Is Pleased To Announce The Closure Of A Service Agreement With Bayer CropScience AG 9/26/2014
BioMotiv Attracts $25 Million Investment From Takeda Pharmaceutical Co. Ltd. (TKPYY) 9/26/2014
Bay Area's Pharmacyclics, Inc. (PCYC) Stock Slumps After Ending Servier Collaboration 9/26/2014
Sagent Pharmaceuticals, Inc.-Hengrui Partnership Launches Second Cancer Drug In U.S. 9/26/2014
Sumitomo Dainippon Pharma, SanBio, Inc. Strike $199 Million Stroke Deal 9/26/2014
PharmaEngine, Inc. And Merrimack Amend MM-398 License Agreement 9/26/2014
Gilead Sciences, Inc. (GILD) Release: The Medicines Patent Pool Adds New Sub-Licensing Agreements To Improve Access To Novel Arvs In Developing Countries 9/25/2014
PHT Corporation Logpad® System Selected By Agile Therapeutics, Inc. For Use In Its Phase 3 Trial Of Twirla® Investigational Contraceptive Patch 9/24/2014
Rhizen Pharmaceuticals S.A. Announces Out-Licensing Agreement For TGR-1202, A Novel Next Generation PI3K-Delta Inhibitor 9/23/2014
Abcam plc (ABC.L) Licenses Novel Ceefourin Inhibitors Of Multidrug Resistance Protein 4 From Australia’s Children’s Cancer Institute 9/22/2014
MediGene AG (MDGEF.PK): New Research Collaborations And Additional Grant For Immunotherapy TABs 9/22/2014
SCHOTT Corporation And Algatechnologies Join R&D Forces 9/22/2014



//-->